Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $atos

$ATOS announces issuance of U.S. patent covering oral (Z)-Endoxifen formulations. Social media buzz highlights upcoming catalysts and positive data presentations.

### About $atos
Atossa Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapeutics for breast cancer.  

### Insights
- $atos sentiment is up XXXXX% from the previous month.
- $atos creators is up XXXXX% from the previous week.
- $atos engagements is up XXXXX% from the previous week.
- $atos mentions is up XXXXX% from the previous week.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$atos/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$atos/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX +71%  
X Month: XXXXXX +4.70%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXX on 2025-07-30  
1-Year Low: XXX on 2025-11-15  

Engagements by network (24h):
X: XXXXX
YouTube: XX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$atos/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$atos/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX +53%  
X Month: XXX -XX%  
X Months: XXXXX -XX%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2024-12-13  
1-Year Low: XX on 2025-09-28  

Mentions by network (24h):
X: XXX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$atos/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$atos/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $atos in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +79%  
X Month: XXX -XX%  
X Months: XXXXX +156%  
X Year: XXXXX +166%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-07  

The most influential creators that mention $atos in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)         | X    | XXXXXX    | X     | XXXXX       |
| [@JeffTheOmega1](/creator/twitter/JeffTheOmega1)   | X    | XXXXX     | X     | XXX         |
| [@Hilljohan750](/creator/twitter/Hilljohan750)     | X    | XX        | X     | XX          |
| [@remon_jon83640](/creator/twitter/remon_jon83640) | X    | X         | X     | X           |

[View More](/list/creators/$atos/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$atos/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$atos/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +12%  
X Month: XXX% +14%  
X Months: XXX% +4%  
X Year: XXX% +12%  
1-Year High: XXX% on 2024-12-18  
1-Year Low: XX% on 2025-10-16  

Most Supportive Themes:
- Trading Group Promotions: (40%) Users are actively promoting $ATOS within trading groups, suggesting a coordinated effort to drive interest and potential price appreciation.
- Mainnet Launch and Airdrop: (30%) Anticipation for the 2026 mainnet launch and associated airdrop is a significant driver of current social buzz and price speculation.
- FDA Feedback and Clinical Trials: (20%) Positive feedback from the FDA and progress in clinical trials are contributing to a favorable outlook for $ATOS.
  
Most Critical Themes:
- Fear of Missing Out (FOMO): (10%) Some users express anxiety about missing out on potential gains, indicating a speculative element within the community.
  

### Top $atos Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Best discord group over 180k members and even have their own app join here $TWTR $GILD $DAL $NNDM $WISH $SRNE $CRON $ATOS $THCH $BTC $ETH $XRP #orderblocktrading"  
[X Link](https://x.com/MSdzvd66208/status/1998439002979111024) [@MSdzvd66208](/creator/x/MSdzvd66208) 2025-12-09T17:06Z XX followers, XX engagements


"📌 Biotech Stock News 12/10 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"  
[X Link](https://x.com/BiopharmIQ/status/1998432564135309794) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-09T16:40Z 28.1K followers, 3443 engagements


"$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998422016311910719) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T15:58Z 3011 followers, XXX engagements


"$ATOS Daily Inv H&S Daily MACD RSI curling Multiple catalysts starting today with data presentation X exhibits going on 12+ months of cash $50m No dilution during 2025 All warrants expired Recent upgraded to $8"  
[X Link](https://x.com/JeffTheOmega1/status/1998404526886236463) [@JeffTheOmega1](/creator/x/JeffTheOmega1) 2025-12-09T14:49Z 4649 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$atos

$ATOS announces issuance of U.S. patent covering oral (Z)-Endoxifen formulations. Social media buzz highlights upcoming catalysts and positive data presentations.

About $atos

Atossa Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapeutics for breast cancer.

Insights

  • $atos sentiment is up XXXXX% from the previous month.
  • $atos creators is up XXXXX% from the previous week.
  • $atos engagements is up XXXXX% from the previous week.
  • $atos mentions is up XXXXX% from the previous week.

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +71%
X Month: XXXXXX +4.70%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-07-30
1-Year Low: XXX on 2025-11-15

Engagements by network (24h): X: XXXXX YouTube: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +53%
X Month: XXX -XX%
X Months: XXXXX -XX%
X Year: XXXXX -XX%
1-Year High: XXX on 2024-12-13
1-Year Low: XX on 2025-09-28

Mentions by network (24h): X: XXX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $atos in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
X Week: XX +79%
X Month: XXX -XX%
X Months: XXXXX +156%
X Year: XXXXX +166%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-07

The most influential creators that mention $atos in the last XX hours

Creator Rank Followers Posts Engagements
@BiopharmIQ X XXXXXX X XXXXX
@JeffTheOmega1 X XXXXX X XXX
@Hilljohan750 X XX X XX
@remon_jon83640 X X X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +12%
X Month: XXX% +14%
X Months: XXX% +4%
X Year: XXX% +12%
1-Year High: XXX% on 2024-12-18
1-Year Low: XX% on 2025-10-16

Most Supportive Themes:

  • Trading Group Promotions: (40%) Users are actively promoting $ATOS within trading groups, suggesting a coordinated effort to drive interest and potential price appreciation.
  • Mainnet Launch and Airdrop: (30%) Anticipation for the 2026 mainnet launch and associated airdrop is a significant driver of current social buzz and price speculation.
  • FDA Feedback and Clinical Trials: (20%) Positive feedback from the FDA and progress in clinical trials are contributing to a favorable outlook for $ATOS.

Most Critical Themes:

  • Fear of Missing Out (FOMO): (10%) Some users express anxiety about missing out on potential gains, indicating a speculative element within the community.

Top $atos Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Best discord group over 180k members and even have their own app join here $TWTR $GILD $DAL $NNDM $WISH $SRNE $CRON $ATOS $THCH $BTC $ETH $XRP #orderblocktrading"
X Link @MSdzvd66208 2025-12-09T17:06Z XX followers, XX engagements

"📌 Biotech Stock News 12/10 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link @BiopharmIQ 2025-12-09T16:40Z 28.1K followers, 3443 engagements

"$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:"
X Link @OzmosiHealth 2025-12-09T15:58Z 3011 followers, XXX engagements

"$ATOS Daily Inv H&S Daily MACD RSI curling Multiple catalysts starting today with data presentation X exhibits going on 12+ months of cash $50m No dilution during 2025 All warrants expired Recent upgraded to $8"
X Link @JeffTheOmega1 2025-12-09T14:49Z 4649 followers, XXX engagements

$atos
/topic/$atos